This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Oct 15;198(8):1105-1106.

doi: 10.1164/rccm.201806-1116LE.

Reply to Rajchgot et al.: Combination Nintedanib and Pirfenidone for Treatment of Idiopathic Pulmonary Fibrosis

Carlo Vancheri¹, Michael Kreuter², Luca Richeldi³, Manuel Quaresma⁴, Susanne Stowasser⁴, Wim A Wuyts⁵

Affiliations

Affiliations

¹ 1 University of Catania Catania, Italy.
² 2 University of Heidelberg Heidelberg, Germany.
³ 3 Fondazione Policlinico A. Gemelli Rome, Italy.
⁴ 4 Boehringer Ingelheim International GmbH Ingelheim am Rhein, Germany and.
⁵ 5 University Hospitals Leuven Leuven, Belgium.

PMID: 30025211
DOI: 10.1164/rccm.201806-1116LE

Comment

Reply to Rajchgot et al.: Combination Nintedanib and Pirfenidone for Treatment of Idiopathic Pulmonary Fibrosis

Carlo Vancheri et al. Am J Respir Crit Care Med. 2018.

. 2018 Oct 15;198(8):1105-1106.

doi: 10.1164/rccm.201806-1116LE.

Authors

Carlo Vancheri¹, Michael Kreuter², Luca Richeldi³, Manuel Quaresma⁴, Susanne Stowasser⁴, Wim A Wuyts⁵

Affiliations

¹ 1 University of Catania Catania, Italy.
² 2 University of Heidelberg Heidelberg, Germany.
³ 3 Fondazione Policlinico A. Gemelli Rome, Italy.
⁴ 4 Boehringer Ingelheim International GmbH Ingelheim am Rhein, Germany and.
⁵ 5 University Hospitals Leuven Leuven, Belgium.

PMID: 30025211
DOI: 10.1164/rccm.201806-1116LE

No abstract available

PubMed Disclaimer

Comment on

Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial.
Vancheri C, Kreuter M, Richeldi L, Ryerson CJ, Valeyre D, Grutters JC, Wiebe S, Stansen W, Quaresma M, Stowasser S, Wuyts WA; INJOURNEY Trial Investigators. Vancheri C, et al. Am J Respir Crit Care Med. 2018 Feb 1;197(3):356-363. doi: 10.1164/rccm.201706-1301OC. Am J Respir Crit Care Med. 2018. PMID: 28889759 Clinical Trial.
Combination Nintedanib and Pirfenidone for Treatment of Idiopathic Pulmonary Fibrosis.
Rajchgot J, Stanbrook MB, Anand A. Rajchgot J, et al. Am J Respir Crit Care Med. 2018 Oct 15;198(8):1105. doi: 10.1164/rccm.201805-0954LE. Am J Respir Crit Care Med. 2018. PMID: 30025213 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations